MedTrace Logo

Controlling Myopia Progression With Soft Contact Lenses (Contact Lens Control)

NCT01829191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression

Conditions

  • Myopia

Interventions

DEVICE

Soft Contact Test Lens A

FDA-approved, non-marketed daily disposable soft contact lens, conventional design

DEVICE

Soft Contact Test Lens C

Daily disposable soft contact lens with new optical design

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-01
Primary Completion
2010-05-01
Completion
2010-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01829191 on ClinicalTrials.gov